Hybrid cardiac magnetic resonance/computed tomographic imaging: first fusion of three-dimensional magnetic resonance perfusion and low-dose coronary computed tomographic angiography A 65-year-old male patient with typical chest pain underwent low-dose coronary computed tomographic (CT) angiography (CCTA) with 1.4 mSv for evaluation of coronary artery disease (CAD). Panel A shows a curved multiplanar reformation of the left circumflex artery with a high-grade stenosis (white arrow) in the large first obtuse marginal branch (OM1). Subsequently, a stress cardiac magnetic resonance perfusion imaging (CMR) (adenosine 140 mg/kg/min, 0.1 mmol/kg Gadobutrolum, kt-SENSE) was performed with a new sequence allowing three-dimensional (3D) perfusion assessment. This revealed a lateral perfusion defect, involving 13% of the left ventricular myocardium (Panel B, white arrowheads). The 3D hybrid CMR/CCTA (obtained using PMOD Technologies Ltd and CardIQ Fusion, GE Healthcare) showed a perfect match of the perfusion defect (white arrowheads) and the culprit lesion (white arrow) (Panel C), documenting a prognostically important finding requiring revascularization. A 50% stenosis of the proximal left anterior descending artery was not associated with any perfusion defect on 3D hybrid CMR/CCTA. Finally, the patient underwent invasive coronary angiography confirming a subtotal occlusion of the OM1 (Panel D, white arrow) which was successfully revascularized. On clinical follow-up, the patient was well and reported no further anginal episodes. To our knowledge, this is the first report on 3D CMR/CT hybrid imaging integrating fullcoverage perfusion information from 3D stress CMR and anatomical information from low-dose CCTA. By spatial colocalization of complementary data sets, hybrid 3D CMR/CT imaging may help to guide revascularization strategies in CAD patients. This latest technical advancement is an important further step in the attempt to reduce radiation burden in non-invasive hybrid imaging (cumulative radiation dose 1.4 mSv). 
